AI Insight
This study analyzed globin gene variants in the updated Genome Aggregation Database (gnomAD) v4.1 compared to v2.1.1 to assess how increased sample size and improved ancestry representation affect variant classification for hemoglobinopathies. The researchers found a fourfold increase in identified globin gene variants, with 68.7% being ancestry-specific, and observed that the updated database enabled more precise allele frequency estimates for rare variants. The improved data allowed for more robust assessment of ACMG/AMP variant classification criteria, with PM2_Supporting criterion fulfillment increasing from 81.5% to 93.5%.
Why it matters
Enhanced variant classification accuracy directly impacts clinical diagnosis and genetic counseling for hemoglobinopathies like sickle cell disease and thalassemia. The improved ancestry representation in gnomAD v4.1 reduces potential disparities in variant interpretation across different populations, leading to more equitable clinical genetic testing outcomes.
Understand the Science
⚠️ Preprint – Noch nicht peer-reviewed
Dieser Artikel wurde noch nicht von unabhängigen Experten begutachtet. Die Ergebnisse sind vorläufig und sollten mit Vorsicht interpretiert werden.
Background Given the augmented sampling and ancestry stratification of the Genome Aggregation Database (gnomAD) v4.1 compared to v2.1.1, population evidence for globin gene variants was assessed for changes in the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) criteria fulfillment, which can alter downstream variant interpretation. Methods Variants and constraint metrics for -globin locus genes HBA1, HBA2, and HBZ, and {beta}-globin locus genes HBB, HBD, HBG1, HBG2, and HBE1, were extracted from gnomAD v2.1.1 and v4.1 callsets, harmonized, matched to ClinVar annotations, and evaluated against BA1, BS1, BS2, BS2_Supporting, and PM2_Supporting ACMG/AMP criteria using Clinical Genome Resource Hemoglobinopathy Variant Curation Expert Panel thresholds. Results Globin gene variants increased fourfold across gnomAD releases, with HBB contributing the largest share. In v4.1, 68.7% of quality-passing variants were ancestry-specific, 14.4% overlapped ClinVar and PM2_Supporting fulfillment rose from 81.5% to 93.5%. Among variants present in both releases, ACMG/AMP population-criterion assessments were largely concordant, with conflicting combinations in <1%. Conclusions Leveraging augmented sampling and improved ancestry representation, gnomAD v4.1 increased globin gene variant discovery, particularly for rare variants, enabling more precise allele frequency estimates and robust assessment of BA1, BS1, and PM2_Supporting, although criterion fulfillment remains release- and callset-specific.